1. Home
  2. DTM vs HALO Comparison

DTM vs HALO Comparison

Compare DTM & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DT Midstream Inc.

DTM

DT Midstream Inc.

SELL

Current Price

$123.13

Market Cap

13.2B

Sector

Utilities

ML Signal

SELL

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

SELL

Current Price

$116.93

Market Cap

12.0B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
DTM
HALO
Founded
2021
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
12.0B
IPO Year
2021
2001

Fundamental Metrics

Financial Performance
Metric
DTM
HALO
Price
$123.13
$116.93
Analyst Decision
Buy
Buy
Analyst Count
15
9
Target Price
★ $151.33
$104.89
AVG Volume (30 Days)
811.1K
★ 2.4M
Earning Date
10-29-2026
11-02-2026
Dividend Yield
★ 2.78%
N/A
EPS Growth
★ 19.44
N/A
EPS
2.36
★ 3.11
Revenue
★ $1,243,000,000.00
$151,862,000.00
Revenue This Year
$9.40
$34.87
Revenue Next Year
$4.03
$10.94
P/E Ratio
$53.62
★ $35.25
Revenue Growth
★ 26.71
N/A
52 Week Low
$104.99
$61.23
52 Week High
$152.88
$116.85

Technical Indicators

Market Signals
Indicator
DTM
HALO
Relative Strength Index (RSI) 43.84 64.26
Support Level $116.98 $105.27
Resistance Level $150.07 N/A
Average True Range (ATR) 2.54 3.28
MACD 0.65 -0.10
Stochastic Oscillator 54.92 81.49

Price Performance

Historical Comparison
DTM
HALO

About DTM DT Midstream Inc.

DT Midstream Inc is an owner, operator, and developer of natural gas midstream interstate and intrastate pipelines; storage and gathering systems; and compression, treatment, and surface facilities. It provides multiple, integrated natural gas services to customers through interstate pipelines, intrastate pipelines, storage systems, lateral pipelines and related treatment plants and compression and surface facilities, and gathering systems and related treatment plants and compression and surface facilities. The segments of the group are Pipeline and Gathering. It generates maximum revenue from pipeline segment that includes interstate pipelines, storage systems, gathering lateral pipelines and compression and surface facilities.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: